Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Off-label Use of Drugs in Children Reported: Korosho Panel
April 5, 2004
- REGULATORY NEWS IN BRIEF
April 5, 2004
- Generics' Share Up to 6.3% on Purchase Price Basis at National Hospitals
April 5, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 5, 2004
- AS-3201 Shows Promise for Diabetic Neuropathy: Dainippon
April 5, 2004
- Merger Synergism Boosts Chugai's Performances: Mr Nagayama
April 5, 2004
- Gastric Cancer Therapeutic GL to Be Revised
April 5, 2004
- WORLD NEWS IN BRIEF
April 5, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 5, 2004
- Asahi Kasei Pharma to Promote Elcitonin for Pain in Osteoporosis
April 5, 2004
- BULLETIN
April 5, 2004
- Midterm Management Plan for Mediceo Group Announced
April 5, 2004
- PRESS SEMINAR
April 5, 2004
- Contract Mfg Now Accounts for Half of Sales: Nipro Pharma
April 5, 2004
- JMA Announces Report on Medical Practices, Bioethics
April 5, 2004
- Drug Organization Investment Project Receives Qualified Praise from Participants: JPMA Survey
April 5, 2004
- OTC NEWS IN BRIEF
April 5, 2004
- BUSINESS NEWS IN BRIEF
April 5, 2004
- Iryo Proverbs Reveal Japanese Spirit (18)
April 5, 2004
- Janssen Pharmaceutical Aims at Sales of \100 Bil. in 2006: Mr Sekiguchi
April 5, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…